← Russell 3000 cross-section

VREX Varex Imaging Corp

Trailing twelve months to 2026-07-03 · as filed 2026-08-10, not restated
Technology

Scale

Market cap
$780m
Revenue TTM
$865m
Net income TTM
$22m
Free cash flow
$-20m
Composite score
39.1
Sector rank
#2170

Valuation

P / E
35.3
EV / EBITDA
10.1
EV / sales
1.2
FCF yield
-2.59%
Earnings yield vs 10-yr
-1.90pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
2.5%
EBITDA margin
11.5%
ROE
4.5%
ROIC
9.9%
Revenue growth
5.3%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Together these items increased gross profit and operating income by approximately $10.1 million and income before taxes by approximately $10.8 million for the third fiscal quarter of fiscal year 2026. Replacement and service of our existing installed base makes up a significant portion of our revenue. Discussion of Results of Operations for the Three Months Ended July 3, 2026 Compared to the Three Months Ended July 4, 2025 Revenues, Net Medical revenues decreased $8.1 million, primarily due to decreased sales of radiography, mammography, CT, Dental and other modalities of $9.5 million, partially offset by increased sales in fluoroscopic and veterinary of $1.4 million. …Varex Imaging Corp, 10-Q, period ended 2026-07-03, filed 2026-08-10

Read the full passage →